Copyright Reports & Markets. All rights reserved.

Global Pregabalin Capsule Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Pregabalin Capsule Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 25mg Capsule
    • 1.3.3 50mg Capsule
    • 1.3.4 75mg Capsule
    • 1.3.5 Others
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Pregabalin Capsule Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Clinics
    • 1.4.3 Hospitals
    • 1.4.4 Others
  • 1.5 Global Pregabalin Capsule Market Size & Forecast
    • 1.5.1 Global Pregabalin Capsule Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Pregabalin Capsule Sales Quantity (2021-2032)
    • 1.5.3 Global Pregabalin Capsule Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Actavis Pharma
    • 2.1.1 Actavis Pharma Details
    • 2.1.2 Actavis Pharma Major Business
    • 2.1.3 Actavis Pharma Pregabalin Capsule Product and Services
    • 2.1.4 Actavis Pharma Pregabalin Capsule Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Actavis Pharma Recent Developments/Updates
  • 2.2 Stat Rx USA
    • 2.2.1 Stat Rx USA Details
    • 2.2.2 Stat Rx USA Major Business
    • 2.2.3 Stat Rx USA Pregabalin Capsule Product and Services
    • 2.2.4 Stat Rx USA Pregabalin Capsule Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Stat Rx USA Recent Developments/Updates
  • 2.3 Accord Healthcare
    • 2.3.1 Accord Healthcare Details
    • 2.3.2 Accord Healthcare Major Business
    • 2.3.3 Accord Healthcare Pregabalin Capsule Product and Services
    • 2.3.4 Accord Healthcare Pregabalin Capsule Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Accord Healthcare Recent Developments/Updates
  • 2.4 Angita Pharma
    • 2.4.1 Angita Pharma Details
    • 2.4.2 Angita Pharma Major Business
    • 2.4.3 Angita Pharma Pregabalin Capsule Product and Services
    • 2.4.4 Angita Pharma Pregabalin Capsule Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Angita Pharma Recent Developments/Updates
  • 2.5 Pfizer
    • 2.5.1 Pfizer Details
    • 2.5.2 Pfizer Major Business
    • 2.5.3 Pfizer Pregabalin Capsule Product and Services
    • 2.5.4 Pfizer Pregabalin Capsule Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Pfizer Recent Developments/Updates
  • 2.6 Succeway Pharmaceuticals
    • 2.6.1 Succeway Pharmaceuticals Details
    • 2.6.2 Succeway Pharmaceuticals Major Business
    • 2.6.3 Succeway Pharmaceuticals Pregabalin Capsule Product and Services
    • 2.6.4 Succeway Pharmaceuticals Pregabalin Capsule Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Succeway Pharmaceuticals Recent Developments/Updates
  • 2.7 Wan Vee Pharm
    • 2.7.1 Wan Vee Pharm Details
    • 2.7.2 Wan Vee Pharm Major Business
    • 2.7.3 Wan Vee Pharm Pregabalin Capsule Product and Services
    • 2.7.4 Wan Vee Pharm Pregabalin Capsule Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Wan Vee Pharm Recent Developments/Updates
  • 2.8 Qilu Pharmaceutical
    • 2.8.1 Qilu Pharmaceutical Details
    • 2.8.2 Qilu Pharmaceutical Major Business
    • 2.8.3 Qilu Pharmaceutical Pregabalin Capsule Product and Services
    • 2.8.4 Qilu Pharmaceutical Pregabalin Capsule Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Qilu Pharmaceutical Recent Developments/Updates

3 Competitive Environment: Pregabalin Capsule by Manufacturer

  • 3.1 Global Pregabalin Capsule Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Pregabalin Capsule Revenue by Manufacturer (2021-2026)
  • 3.3 Global Pregabalin Capsule Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Pregabalin Capsule by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Pregabalin Capsule Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Pregabalin Capsule Manufacturer Market Share in 2025
  • 3.5 Pregabalin Capsule Market: Overall Company Footprint Analysis
    • 3.5.1 Pregabalin Capsule Market: Region Footprint
    • 3.5.2 Pregabalin Capsule Market: Company Product Type Footprint
    • 3.5.3 Pregabalin Capsule Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Pregabalin Capsule Market Size by Region
    • 4.1.1 Global Pregabalin Capsule Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Pregabalin Capsule Consumption Value by Region (2021-2032)
    • 4.1.3 Global Pregabalin Capsule Average Price by Region (2021-2032)
  • 4.2 North America Pregabalin Capsule Consumption Value (2021-2032)
  • 4.3 Europe Pregabalin Capsule Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Pregabalin Capsule Consumption Value (2021-2032)
  • 4.5 South America Pregabalin Capsule Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Pregabalin Capsule Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Pregabalin Capsule Sales Quantity by Type (2021-2032)
  • 5.2 Global Pregabalin Capsule Consumption Value by Type (2021-2032)
  • 5.3 Global Pregabalin Capsule Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Pregabalin Capsule Sales Quantity by Application (2021-2032)
  • 6.2 Global Pregabalin Capsule Consumption Value by Application (2021-2032)
  • 6.3 Global Pregabalin Capsule Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Pregabalin Capsule Sales Quantity by Type (2021-2032)
  • 7.2 North America Pregabalin Capsule Sales Quantity by Application (2021-2032)
  • 7.3 North America Pregabalin Capsule Market Size by Country
    • 7.3.1 North America Pregabalin Capsule Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Pregabalin Capsule Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Pregabalin Capsule Sales Quantity by Type (2021-2032)
  • 8.2 Europe Pregabalin Capsule Sales Quantity by Application (2021-2032)
  • 8.3 Europe Pregabalin Capsule Market Size by Country
    • 8.3.1 Europe Pregabalin Capsule Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Pregabalin Capsule Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Pregabalin Capsule Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Pregabalin Capsule Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Pregabalin Capsule Market Size by Region
    • 9.3.1 Asia-Pacific Pregabalin Capsule Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Pregabalin Capsule Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Pregabalin Capsule Sales Quantity by Type (2021-2032)
  • 10.2 South America Pregabalin Capsule Sales Quantity by Application (2021-2032)
  • 10.3 South America Pregabalin Capsule Market Size by Country
    • 10.3.1 South America Pregabalin Capsule Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Pregabalin Capsule Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Pregabalin Capsule Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Pregabalin Capsule Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Pregabalin Capsule Market Size by Country
    • 11.3.1 Middle East & Africa Pregabalin Capsule Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Pregabalin Capsule Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Pregabalin Capsule Market Drivers
  • 12.2 Pregabalin Capsule Market Restraints
  • 12.3 Pregabalin Capsule Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Pregabalin Capsule and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Pregabalin Capsule
  • 13.3 Pregabalin Capsule Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Pregabalin Capsule Typical Distributors
  • 14.3 Pregabalin Capsule Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Pregabalin Capsule market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
    Pregabalin is an anticonvulsant drug used to treat neuropathic pain conditions and fibromyalgia, and for the treatment of partial onset seizures in combination with other anticonvulsants.
    The global market may be influenced by the prevalence of conditions, as well as healthcare infrastructure and access to healthcare in different regions.The patent status of a drug can significantly influence market trends. If the patent has expired or is close to expiring, it can lead to the entry of generic versions, which can affect market dynamics, pricing, and competition.Market trends may be influenced by the approval of new indications or the expansion of the drug"s approved use. If new indications receives approval for additional medical conditions, it could potentially lead to increased sales and market growth.
    This report is a detailed and comprehensive analysis for global Pregabalin Capsule market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Pregabalin Capsule market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Pregabalin Capsule market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Pregabalin Capsule market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Pregabalin Capsule market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Pregabalin Capsule
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Pregabalin Capsule market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Actavis Pharma, Stat Rx USA, Accord Healthcare, Angita Pharma, Pfizer, Succeway Pharmaceuticals, Wan Vee Pharm, Qilu Pharmaceutical, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Pregabalin Capsule market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    25mg Capsule
    50mg Capsule
    75mg Capsule
    Others
    Market segment by Application
    Clinics
    Hospitals
    Others
    Major players covered
    Actavis Pharma
    Stat Rx USA
    Accord Healthcare
    Angita Pharma
    Pfizer
    Succeway Pharmaceuticals
    Wan Vee Pharm
    Qilu Pharmaceutical
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Pregabalin Capsule product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Pregabalin Capsule, with price, sales quantity, revenue, and global market share of Pregabalin Capsule from 2021 to 2026.
    Chapter 3, the Pregabalin Capsule competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Pregabalin Capsule breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Pregabalin Capsule market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Pregabalin Capsule.
    Chapter 14 and 15, to describe Pregabalin Capsule sales channel, distributors, customers, research findings and conclusion.

    Buy now